Di-n-butyltin(IV) di-o-bromobenzoate, a weakly-bridged dimer

DOI: 10.1016/0022-328X(90)80199-A

Source and publish data:

Journal of Organometallic Chemistry p. 201 - 204 (1990)

Update date:2022-08-03

Topics:

Authors:

Ng, Seik Weng

Das, V.G. Kumar

Yip, Wai-Hing

Wang, Ru-Ji

Mak, Thomas C.W.

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1016/0022-328X(90)80199-A

The six-coordinated tin in di-n-butyltin di-o-bromobenzoate has a skew-trapezoidal bipyramidal geometry with a C-Sn-C angle of 140.5(3) deg.The molecules are packed in the unit cell as weakly-bridged dimers Sn...O 3.451(5) Angstroem).

Full text of DOI:10.1016/0022-328X(90)80199-A

Products guided by the article

Product name:di-n-butyltin(IV) di-o-bromobenzoate

Cas No:130651-89-7

R&D Labs maybe for 130651-89-7

QUZHOU ZIO I/E CO.;LTD

Contact:13357117572

Address:No.149 Shiji dadao Road.
Shanghai Yurui Biotechnology(Anyang) Pharmaceutical Co., Ltd

Contact:+86-0372-3662335 +86-0372-3661988

Address:hanling industrial park anyang
WUHAN WELLSONG INT'L CO.,LTD

Contact:+86-27-85733560

Address:NO.308,QINGNIAN RD.,WUHAN,CHINA
Shanghai Apeptide Co., Ltd.

website:http://www.apeptides.com/en/

Contact:+86-21-60871011

Address:No. 80 Chuanshan Shuyuan Steet,Pudong,Shanghai
Onlychem (Jinan)Biotech Co.,Ltd

Contact:86-531-83175885

Address:No. 44, Honglou South Road, Jinan,China

Relevant to this article

Facile and enantiospecific syntheses of (6 S,7 R)-6-chloro-7-BENZYLOXY-, (7 S)-halo-, and (7 S)-hydroxy-cocaine and natural (-)-cocaine from d -(-)-ribose

Doi:10.1021/ol2009686
(2011)
Doi:10.1021/ja01255a026
(1942)
Synthesis of antitumor ansamycins. 2. A formal synthesis of (±)-macbecin I

Doi:10.1016/S0040-4039(00)97607-X
(1990)
Doi:10.1007/BF00636026
()
Novel tandem reaction for the synthesis of Na′-substituted 2-imino-1,3-oxazolidines from vicinal (sec- or tert-)amino alcohol of desosamine

Doi:10.1002/ejoc.201001707
(2011)
Novel pyrrolidine melanin-concentrating hormone receptor 1 antagonists with reduced hERG inhibition

Doi:10.1016/j.bmcl.2011.02.046
(2011)

Article Doi